Markets:

Overview

News

Currencies

International

Treasuries

MDxHealth SA - Ordinary Shares (NQ:MDXH)

3.370 -0.010 (-0.30%)

Streaming Delayed Price Updated: 11:56 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MDxHealth SA - Ordinary Shares

< Previous 1 2 3 Next >

Crude Oil Down Over 2%; US Initial Jobless Claims Fall ↗

September 26, 2024

Via Benzinga

Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results ↗

September 26, 2024

Via Benzinga

Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2024

Via Benzinga

MDxHealth Announces Pricing of Offering of Ordinary Shares

September 25, 2024

From mdxhealth

Via GlobeNewswire

BTIG Maintains Buy Rating for MDxHealth: Here's What You Need To Know ↗

May 16, 2023

Via Benzinga

MDxHealth Announces Launch of Offering of Ordinary Shares

September 25, 2024

From mdxhealth

Via GlobeNewswire

MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q2 2024 ↗

August 21, 2024

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

MDxHealth Reports Q2 and Half Year 2024 Results

August 21, 2024

From mdxhealth

Via GlobeNewswire

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

August 12, 2024

From mdxhealth

Via GlobeNewswire

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

July 08, 2024

From mdxhealth

Via GlobeNewswire

Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors

July 08, 2024

From mdxhealth

Via GlobeNewswire

Mdxhealth to Present at Upcoming Investor Conferences

May 15, 2024

From mdxhealth

Via GlobeNewswire

MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

May 01, 2024

From mdxhealth

Via GlobeNewswire

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

March 12, 2024

From mdxhealth

Via GlobeNewswire

These Analysts Increase Their Forecasts On MDxHealth After Q4 Results ↗

March 07, 2024

MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday.

Via Benzinga

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

March 06, 2024

From mdxhealth

Via GlobeNewswire

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

February 21, 2024

From mdxhealth

Via GlobeNewswire

TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday ↗

January 09, 2024

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 10, 2023

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Via Benzinga

Earnings Scheduled For March 6, 2024 ↗

March 06, 2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 10, 2023

Via Benzinga

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

August 10, 2023

Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 10, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023 ↗

May 31, 2023

Via Benzinga

Short Volatility Alert: Mdxhealth ↗

April 25, 2023

On Monday, shares of Mdxhealth (NASDAQ: MDXH) experienced volatile short activity. After the activity, the stock price went up +2.78% to $4.07. The overall sentiment for MDXH has been Bearish.

Via Benzinga

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 20, 2023

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...

Via Benzinga

Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results ↗

April 20, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 20, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.